Martin H. Koldijk

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Damian C. Ekiert, Robert H. Friesen, Gira Bhabha et al. · Science · 2011 · 861 citations

Pharmacy, Immunology, Infectious Diseases +17

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines

Maria Grazia Pau, C. Ophorst, Martin H. Koldijk et al. · Vaccine · 2001 · 197 citations

Life Sciences, Biotechnology, Immunology +16

Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease

Pim J. Koelink, Manon E. Wildenberg, Larry Stitt et al. · Journal of Crohn s and Colitis · 2018 · 175 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +16

New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets

Robert H. Friesen, Wouter Koudstaal, Martin H. Koldijk et al. · PLoS ONE · 2010 · 103 citations · Full text

Pharmacy, Immunology, Infectious Diseases +14

Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults

Janeta Nikolovski, Martin H. Koldijk, Gerrit Jan Weverling et al. · PLoS ONE · 2021 · 84 citations · Full text

Veterinary Medicine, Population Health Sciences, Preventive Medicine +17